Metronidazole Aurobindo (Metronidazole)

Metronidazole is taken up by anaerobic bacteria and protozoa, where intracellular reduction of its nitro group creates reactive radicals. These radicals damage microbial DNA and inhibit nucleic acid synthesis, leading to cell death while sparing most aerobic cells.

The specific dose and duration of Metronidazole Aurobindo are determined by the prescribing clinician based on the infection type, severity, patient age, weight and renal or hepatic function. Patients should follow the exact regimen provided on the prescription label.

Safety of Metronidazole in pregnancy or lactation depends on the trimester and clinical necessity. It is generally avoided in the first trimester unless benefits outweigh risks, and caution is advised while breastfeeding. Physicians should evaluate each case individually.

To request Metronidazole Aurobindo, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Metronidazole is a first‑line nitroimidazole with broad activity against anaerobic bacteria and protozoa, offering oral convenience and a well‑characterised safety profile. Alternatives such as tinidazole have similar efficacy but differ in dosing frequency and side‑effect spectrum, making Metronidazole a common choice for many indications.

Metronidazole Aurobindo tablets should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original container, protect it from moisture and direct sunlight, and ensure the packaging remains tightly closed until use.

Metronidazole Aurobindo is supplied as oral tablets that are swallowed whole with a glass of water. It may be taken with or without food, although taking it with meals can reduce gastrointestinal upset in some patients.

Serious adverse reactions to Metronidazole include peripheral neuropathy, seizures and severe allergic responses such as anaphylaxis. Patients should seek immediate medical attention if they experience numbness, tingling, convulsions, rash, swelling or breathing difficulties.

Metronidazole Aurobindo is contraindicated in individuals with a known hypersensitivity to metronidazole or other nitroimidazoles. It should also be avoided in patients with severe hepatic impairment or those who are concurrently using disulfiram, due to the risk of a disulfiram‑like reaction.